R-U

64mg Reconcile for Dogs is a veterinary prescription medication that contains fluoxetine.

Reconcile 64mg is available as chewable tablets and it's indicated as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination).

Reconcile for Dogs aids in the treatment of separation-related disorders in dogs. These disorders are often manifested by destructive and inappropriate behaviours, such as vocalisation and inappropriate defecation and/or urination, particularly when the dog is left alone.

Reconcile 64mg for Dogs is a once-a-day, flavoured, chewable tablet that is prescribed by your veterinarian. The active ingredient is fluoxetine, an antidepressant that works by increasing the levels of serotonin in the dog's brain. This helps to achieve a calmer frame of mind in dogs, making them more receptive to behaviour modification training.

Separation anxiety is a condition that affects up to 17% of dogs. It can be inherited or acquired, depending on the dog’s history and experiences. The anxiety develops when the dog is unable to soothe their anxiety without the assistance of their caregiver, or when being alone is associated with uncertainty or fear-inducing signals such as noise.

VETERINARY PRESCRIPTION REQUIRED

32mg Reconcile for Dogs is a veterinary prescription medication that contains fluoxetine. Reconcile 32mg is available as chewable tablets and it's indicated as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination). VETERINARY PRESCRIPTION REQUIRED

16mg Reconcile for Dogs is a veterinary prescription medication that contains fluoxetine. Reconcile 16mg is available as chewable tablets and it's indicated as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination). VETERINARY PRESCRIPTION REQUIRED

Simparica Trio 72mg Chewable Tablets for Dogs (40kg-60kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 6

Simparica Trio 72mg Chewable Tablets for Dogs (40kg-60kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3

Simparica Trio 48mg Chewable Tablets for Dogs (20kg-40kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 6

Simparica Trio 48mg Chewable Tablets for Dogs (20kg-40kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3

Simparica Trio 24mg Chewable Tablets for Dogs (10kg-20kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3

Simparica Trio 24mg Chewable Tablets for Dogs (10kg-20kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3

Simparica Trio 12mg Chewable Tablets for Dogs (5kg-10kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 6

Simparica Trio 12mg Chewable Tablets for Dogs (5kg-10kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 3

Simparica Trio 6mg Chewable Tablets for Dogs (2.5kg-5kg) are indicated for the treatment of dogs with, or at risk from, mixed external and internal parasitic infestations. Simparica Trio is exclusively indicated when use against ticks or fleas, and gastrointestinal nematodes are indicated at the same time. Simparica Trio also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis. Pack of 6